Use of low-dose combined therapy with gemcitabine and paclitaxel for advanced urothelial cancer patients with resistance to cisplatin-containing therapy: a retrospective analysis.
about
Ethaselen: a novel organoselenium anticancer agent targeting thioredoxin reductase 1 reverses cisplatin resistance in drug-resistant K562 cells by inducing apoptosis.Safety and efficacy of combination therapy with low-dose gemcitabine, paclitaxel, and sorafenib in patients with cisplatin-resistant urothelial cancer.Apoptotic effect of cordycepin combined with cisplatin and/or paclitaxel on MA-10 mouse Leydig tumor cellsPromotion of mitotic catastrophe via activation of PTEN by paclitaxel with supplement of mulberry water extract in bladder cancer cellsHuman antigen R as a predictive marker for response to gemcitabine-based chemotherapy in advanced cisplatin-resistant urothelial cancer.
P2860
Use of low-dose combined therapy with gemcitabine and paclitaxel for advanced urothelial cancer patients with resistance to cisplatin-containing therapy: a retrospective analysis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Use of low-dose combined thera ...... apy: a retrospective analysis.
@ast
Use of low-dose combined thera ...... apy: a retrospective analysis.
@en
type
label
Use of low-dose combined thera ...... apy: a retrospective analysis.
@ast
Use of low-dose combined thera ...... apy: a retrospective analysis.
@en
prefLabel
Use of low-dose combined thera ...... apy: a retrospective analysis.
@ast
Use of low-dose combined thera ...... apy: a retrospective analysis.
@en
P2093
P2860
P1476
Use of low-dose combined thera ...... apy: a retrospective analysis.
@en
P2093
Hideki Sakai
Hiroshi Kanetake
Koichiro Nomata
Kojiro Ohba
Tomohiro Matsuo
Yasuyoshi Miyata
Yuji Sagara
P2860
P2888
P304
P356
10.1007/S00280-012-1938-3
P577
2012-08-03T00:00:00Z